NEUROCRINE BIOSCIENCES INC (NBIX)
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
Bath & Body Works Declares Cash Dividend
Direct Digital Holdings to Report Second Quarter 2026 Financial Results
Mandatory Cash Dividend/ Distribution:
Financial Statements and Related Announcement: Half Yearly Results
Financial Statements and Related Announcement: Half Yearly Results
BTGO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026
Found Industries Opens Cambridge Headquarters and Found Metals Process Development Center
Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan
Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) Announces Letter of Intent for Proposed Reverse Takeover Transaction with Privately Held Operating Company